That's interesting, I hadn't considered that viewpoint. Cheers
Three follow up questions that come to mind.
- Why do you think the two sides will be too far apart to reach agreement?
- Do you think having multiple large pharma groups competing for Bisantrene will change this prediction?
- How do you incorporate other pharma transactions that have occured without prior partnerships into this view?
What's going on with Race Oncology at the moment ?, page-43
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
-0.040(2.47%) |
Mkt cap ! $267.4M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.65 | $1.54 | $132.0K | 83.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5406 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 406 | 1 |
View Market Depth
| Last trade - 15.20pm 31/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |